153 related articles for article (PubMed ID: 5067494)
1. Systemic and hemodynamic effects of oral hexobendine in dogs.
Hansing CE; Folts JD; Afonso S; Rowe GG
Arzneimittelforschung; 1972 Feb; 22(2):398-402. PubMed ID: 5067494
[No Abstract] [Full Text] [Related]
2. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
Hansing CE; Folts JD; Afonso S; Rowe GG
J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
[No Abstract] [Full Text] [Related]
3. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
Reploh HD
Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
[No Abstract] [Full Text] [Related]
4. [Effects of dilazep on cardiac function, coronary circulation and myocardial energy metabolism].
Katano Y; Takeda K; Otorii T; Horii D; Imai S
Nihon Yakurigaku Zasshi; 1974 Mar; 70(2):305-14. PubMed ID: 4858949
[No Abstract] [Full Text] [Related]
5. [Effect of 1,4-bis(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine dihydrochloride on cardiac metabolism, hemodynamics and coronary and renal blood flow].
Hensel I; Bretschneider HJ; Kettler D; Knoll D; Kochsiek K; Reploh HD; Spieckermann PG; Tauchert M
Arzneimittelforschung; 1972 Apr; 22(4):652-63. PubMed ID: 5068243
[No Abstract] [Full Text] [Related]
6. Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401).
Sato M; Nagao T; Yamaguchi I; Nakajima H; Kiyomoto A
Arzneimittelforschung; 1971 Sep; 21(9):1338-43. PubMed ID: 5171789
[No Abstract] [Full Text] [Related]
7. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
Rowe GG; Terry W; Stenlund RR; Thomsen JH; Querimit AS
Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):99-103. PubMed ID: 5353477
[No Abstract] [Full Text] [Related]
8. [Pharmacology of 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-perhydro-1,4-diazepine (dilazep I.N.N.), a new coronary active substance].
Lenke D; Brock N; Zechel HJ
Arzneimittelforschung; 1972 Apr; 22(4):639-51. PubMed ID: 5068242
[No Abstract] [Full Text] [Related]
9. Some acute hemodynamic effects of large doses of sodium allopurinol in open-chested dogs.
Ellis CH; Touw KB; Dickerson SW
Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):355-67. PubMed ID: 4766552
[No Abstract] [Full Text] [Related]
10. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
Raff WK; Kosche F; Lochner W
Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
[No Abstract] [Full Text] [Related]
11. Systemic and coronary hemodynamic effects of perhexiline.
Rowe GG; Spring DA; Afonso S
Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275
[No Abstract] [Full Text] [Related]
12. [Effect of andiamine and intensain on some hemodynamic factors].
Sawiński J; Wójcicki J
Wiad Lek; 1974 Sep; 27(16):1443-7. PubMed ID: 4409349
[No Abstract] [Full Text] [Related]
13. [The pharmacology of the combination drug dilazep/beta-acetyldigoxin].
Zechel VH; Brock N
Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1905-14. PubMed ID: 4480353
[No Abstract] [Full Text] [Related]
14. [Effect of hexobendine on the arterial and coronary venous CO2 tension and hydrogen-ion concentration in dogs. Contribution on the theory of the mechanism of action of coronary dilator agents].
Kraupp O; Grossmann W; Stühlinger W; Raberger G
Arzneimittelforschung; 1968 Aug; 18(8):1067-73. PubMed ID: 5755840
[No Abstract] [Full Text] [Related]
15. Cardiohemodynamic effects of BAY a 1040 in the dog.
Hashimoto K; Taira N; Chiba S; Hashimoto K; Endo M
Arzneimittelforschung; 1972 Jan; 22(1):15-21. PubMed ID: 5066992
[No Abstract] [Full Text] [Related]
16. Enhancement of coronary vasodilator action of adenosne by 1,4-Bis-(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine (Dilazep I.N.N.).
Sano N; Katsuki S; Kawada M
Arzneimittelforschung; 1972 Oct; 22(10):1655-8. PubMed ID: 4677053
[No Abstract] [Full Text] [Related]
17. [Effect of hexobendine on the coronary efficacy of generalized hypoxia as well as of i.cor. and i.v. single injections of adenosine in dogs].
Raberger G; Weissel M; Kraupp O
Arzneimittelforschung; 1973 Jun; 23(6):764-8. PubMed ID: 4740758
[No Abstract] [Full Text] [Related]
18. [Screening of substances with coronary vasodilator action].
Lenke D
Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
[No Abstract] [Full Text] [Related]
19. Systemic and coronary hemodynamic effects of Abbott (40557) and its interaction with aminophylline.
Afonso S; Henderson RR; Folts JD; Rowe GG
Basic Res Cardiol; 1975; 70(4):390-400. PubMed ID: 1191207
[TBL] [Abstract][Full Text] [Related]
20. Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
Buyniski JP; Losada M; Bierwagen ME; Gardier RW
J Pharmacol Exp Ther; 1972 Jun; 181(3):522-8. PubMed ID: 5033017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
